Impact and potential value of immunosenescence on solid gastrointestinal tumors
T Zhang, R Wen, H Fan, Y Yu, H Jia, Z Peng… - Frontiers in …, 2024 - frontiersin.org
Solid gastrointestinal tumors often respond poorly to immunotherapy for the complex tumor
microenvironment (TME), which is exacerbated by immune system alterations …
microenvironment (TME), which is exacerbated by immune system alterations …
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients≥ 75 years: results of a real-world cohort including 456 patients
A Gawaz, I Wolff, L Nanz, L Flatz… - Cancer Immunology …, 2024 - Springer
Background Immune checkpoint inhibitors (ICI) applied in patients with melanoma in an
adjuvant setting have proven safety and efficacy in several studies, but data on elderly …
adjuvant setting have proven safety and efficacy in several studies, but data on elderly …
Efficacy of adjuvant immune checkpoint inhibitors in melanoma patients≥ 75 years–results of a real-world cohort including 456 patients
A Gawaz, I Wolff, L Flatz, A Forschner - 2024 - researchsquare.com
Background Immune checkpoint inhibitors (ICI) applied in patients with melanoma in an
adjuvant setting have proved safety and efficacy in several studies, but data on elderly …
adjuvant setting have proved safety and efficacy in several studies, but data on elderly …